use
effect
immunosuppress
explor
prevent
graft
reject
graftversushost
diseas
gvhd
solid
organ
transplant
sot
hematopoiet
stem
cell
transplant
hsct
howev
immunocompromis
condit
induc
exacerb
risk
opportunist
infect
communityacquir
respiratori
virus
carv
well
multidrugresist
bacteria
mold
increasingli
becom
great
import
compris
larg
burden
posttranspl
infect
carv
caus
lower
respiratori
tract
infect
lrti
result
mortal
lifethreaten
morbid
transplant
recipi
sot
hsct
recipi
face
differ
hurdl
suscept
carv
infect
carvi
within
posttranspl
timefram
hsct
recipi
mainli
suscept
sever
carvi
earli
posttranspl
period
includ
preengraft
prolong
neutropenia
sot
recipi
could
risk
carvi
commun
time
posttranspl
period
nontranspl
critic
ill
patient
intens
care
unit
icu
anoth
group
vulner
invas
carvi
among
patient
sever
rhinoviru
pneumonia
diagnos
use
reversetranscript
polymeras
chain
reaction
rtpcr
transplant
compris
major
underli
condit
et
al
choi
et
al
patient
acut
respiratori
failur
respiratori
syncyti
viru
rsv
also
transplant
recipi
respiratori
infect
caus
carv
apart
season
influenza
ab
may
underdiagnos
introduct
multiplex
rtpcr
method
diagnosi
precis
speci
carvi
becam
possibl
carv
great
clinic
signific
sever
immunocompromis
patient
epidemiolog
clinic
outcom
adenoviru
adv
human
metapneumoviru
hmpv
parainfluenza
piv
rsv
sot
hsct
recipi
report
past
decad
howev
report
uniqu
featur
impact
outcom
mortal
carvi
nontranspl
critic
ill
patient
icu
compar
transplant
recipi
even
though
mani
report
focus
comparison
specif
carvi
particularli
season
influenza
viru
sot
hsct
recipi
clinic
inform
carvi
suscept
group
help
clinician
need
consid
differ
strategi
practic
treat
carv
especi
sever
lrti
case
among
transplant
recipi
nontranspl
critic
ill
patient
icu
studi
aim
evalu
characterist
outcom
symptomat
respiratori
infect
result
carv
besid
season
influenza
ab
nontranspl
critic
ill
patient
admit
icu
transplant
recipi
retrospect
cohort
studi
retriev
data
regard
test
includ
multiplex
rtpcr
cultur
carv
adv
coronaviru
cov
human
bocaviru
hbov
hmpv
piv
rhinoviru
rsv
ab
sot
hsct
recipi
nontranspl
critic
ill
patient
icu
year
age
admit
novemb
novemb
sever
hospit
universityaffili
tertiarycar
center
seoul
includ
season
influenza
ab
could
diagnos
use
rapid
antigen
test
besid
rtpcr
cultur
studi
carv
test
perform
patient
suspicion
symptomat
carvi
base
respect
clinician
judgement
exclud
carv
test
perform
pretranspl
period
recipi
receiv
sot
hsct
retransplant
thereaft
carv
test
result
sot
hsct
recipi
respect
final
includ
nontranspl
critic
ill
patient
icu
undergon
carv
test
fig
repeat
ident
carv
isol
one
patient
within
day
consid
infect
therefor
cohort
includ
carvi
case
sot
hsct
recipi
respect
carvi
case
nontranspl
critic
ill
patient
icu
fig
tabl
studi
approv
gangnam
sever
hospit
institut
review
board
need
inform
consent
waiv
due
retrospect
natur
studi
rv
multiplex
realtim
rtpcr
kit
taqman
probe
advansur
lg
life
scienc
seoul
south
carv
test
perform
respiratori
infect
symptom
fever
cough
sputum
note
patient
clinic
suspect
carvi
case
one
carv
repeatedli
detect
differ
time
point
two
carv
simultan
detect
one
patient
consid
sever
isol
caus
carv
within
day
one
patient
one
carvi
case
abnorm
find
chest
radiographi
andor
chest
comput
tomographi
ct
scan
defin
presenc
newli
develop
lung
parenchym
infiltr
determin
radiologist
categor
season
variat
base
spring
marchemay
summer
juneeaugust
autumn
septemberenovemb
winter
decemberefebruari
data
express
number
percent
mean
ae
standard
deviat
median
interquartil
rang
iqr
accord
whether
follow
normal
distribut
categor
variabl
compar
use
chisquar
test
fisher
exact
test
posthoc
analysi
via
bonferroni
correct
base
adjust
standard
residu
use
control
type
error
inflat
adjust
p
use
parametr
independ
ttest
analysi
varianc
anova
test
compar
continu
variabl
normal
distribut
two
three
group
respect
continu
variabl
without
normal
distribut
two
three
group
compar
use
non
carv
isol
cultur
test
minor
patient
describ
posit
rate
kind
carv
multiplex
rtpcr
test
perform
base
clinic
suspicion
symptomat
carvi
three
differ
group
supplementari
tabl
posit
rhinoviru
higher
sot
hsct
recipi
nontranspl
critic
ill
patient
icu
vs
p
z
hsct
recipi
posit
rate
adv
promin
posit
rate
carv
show
signific
differ
three
group
adv
p
hbov
p
p
z
rhinoviru
p
z
rsv
ab
p
z
overal
carv
posit
rate
highest
hsct
recipi
sot
recipi
hsct
recipi
nontranspl
critic
ill
patient
icu
p
z
supplementari
tabl
analys
total
carvi
case
adv
hbov
rhinoviru
significantli
differ
proport
three
group
p
z
respect
highest
frequenc
hsct
recipi
adv
hbov
sot
recipi
rhinoviru
percentag
adv
infect
hsct
recipi
significantli
higher
compar
sot
recipi
nontranspl
critic
ill
patient
icu
hsct
recipi
significantli
lower
percentag
rhinoviru
infect
sot
recipi
tabl
analyz
characterist
carvi
three
group
impact
carvi
outcom
allcaus
inhospit
mortal
tabl
common
allograft
carvsinfect
sot
recipi
kidney
follow
lung
liver
total
carvsinfect
hsct
recipi
receiv
transplant
allogen
donor
stem
cell
sourc
peripher
blood
respect
age
male
sex
total
durat
hospit
stay
time
carvi
significantli
differ
among
three
group
p
respect
nontranspl
critic
ill
patient
icu
oldest
ae
yearold
stay
hospit
longest
period
median
day
iqr
day
total
durat
icu
stay
significantli
differ
nontranspl
critic
ill
patient
icu
transplant
recipi
ever
receiv
icu
sot
hsct
recipi
time
interv
transplant
carvi
significantli
longer
sot
recipi
hsct
recipi
vs
month
p
z
tabl
fig
season
carvi
incid
differ
three
group
p
z
sot
recipi
significantli
lowest
allcaus
inhospit
mortal
among
three
group
p
z
tabl
fig
patient
die
hospit
due
caus
death
carvi
significantli
older
ae
vs
ae
p
z
significantli
higher
percentag
administr
intraven
immunoglobulin
vs
p
mechan
ventil
mv
vs
p
aliv
tabl
carvinfect
patient
similar
rate
allcaus
inhospit
death
adv
hbov
cov
hmpv
piv
rhinoviru
rsv
ab
analys
relat
carv
allcaus
inhospit
mortal
three
group
infect
carv
show
significantli
differ
mortal
rate
supplementari
tabl
cox
proport
hazard
regress
model
mv
independ
risk
factor
associ
higher
allcaus
inhospit
mortal
hr
ci
p
transplant
independ
relat
mortal
tabl
frequenc
carv
except
season
influenza
ab
among
three
highrisk
group
heterogen
despit
signific
differ
overal
frequenc
overal
frequenc
highest
hsct
recipi
studi
reveal
proport
carv
speci
vulner
age
allcaus
mortal
symptomat
carvi
differ
sot
hsct
recipi
nontranspl
critic
ill
patient
icu
group
popul
typic
risk
invas
viral
infect
one
major
find
adv
caus
significantli
higher
rate
respiratori
infect
adult
hsct
recipi
compar
nonimmunocompet
group
sever
studi
report
incid
mortal
due
adv
infect
hsct
recipi
respect
typic
higher
sot
recipi
similar
find
rel
wide
rang
could
due
characterist
studi
popul
includ
potent
condit
chemotherapi
underli
hematolog
malign
type
repetit
hsct
era
occurr
gvhd
studi
larg
proport
carv
except
season
influenza
result
symptomat
respiratori
infect
late
posttranspl
period
median
month
hsct
month
sot
recipi
like
previou
report
data
also
show
posttranspl
period
carvi
occur
sot
recipi
significantli
longer
hsct
recipi
find
suggest
physician
need
suspect
diagnosi
carvi
transplant
recipi
respiratori
symptom
regardless
posttranspl
period
anoth
import
find
studi
nontranspl
critic
ill
patient
icu
group
high
mortal
rate
carvi
rather
transplant
recipi
analys
mortal
show
mv
tradit
risk
factor
indic
sever
lrti
independ
risk
factor
allcaus
inhospit
mortal
three
immunosuppress
group
carvi
speci
carv
independ
lead
increas
mortal
even
though
sot
recipi
kind
carvi
lowest
mortal
rate
three
highrisk
group
find
independ
effect
sot
allcaus
mortal
cox
proport
hazard
regress
model
data
show
hbov
recent
emerg
carv
transplant
occur
five
transplant
recipi
although
report
hbov
caus
sever
dissemin
infect
infant
children
recipi
incid
attribut
mortal
effect
hbov
graft
adult
recipi
remain
unclear
futur
multicent
observ
studi
help
verifi
role
hbov
sever
immunocompromis
patient
even
though
carv
test
show
lowest
posit
rate
nontranspl
critic
ill
patient
icu
group
frequenc
hmpv
rsv
ab
infect
associ
detriment
outcom
treat
specif
antivir
agent
group
differ
compar
transplant
recipi
nontranspl
patient
suspect
sepsi
previou
studi
rsv
ab
hmpv
et
al
report
hmpv
rsv
among
nontranspl
patient
admit
icu
mv
therapi
prospect
multicent
studi
recent
report
support
find
indic
hmpv
rsv
regard
neglig
pathogen
could
underdiagnos
nontranspl
critic
ill
patient
particular
ventil
icu
care
howev
consensu
carv
directli
relat
poor
outcom
attribut
mortal
popul
addit
standard
guidelin
prevent
treatment
carv
among
transplant
recipi
nontranspl
critic
ill
patient
icu
therefor
guidelin
indic
surveil
diagnost
test
well
treatment
specif
carv
uniqu
highrisk
subpopul
prospect
studi
need
standard
implement
practic
effect
studi
sever
limit
carv
test
perform
base
decis
individu
clinician
accord
standard
uniform
protocol
unit
prescript
criteria
could
result
overprescript
lead
lower
posit
rate
well
underprescript
suspicion
carvi
retrospect
data
collect
preclud
us
obtain
precis
incid
rate
accord
year
season
nevertheless
comprehens
data
nearli
total
exclus
multiplex
rtpcr
test
studi
seen
strength
addit
data
demonstr
recipi
sot
hsct
differ
frequenc
carvi
compar
nontranspl
critic
ill
patient
icu
three
highrisk
group
posit
rate
carv
rtpcr
test
detect
larg
scale
one
hospit
data
one
hospit
might
ensur
homogen
sever
consist
laboratori
test
studi
popul
conclus
nontranspl
critic
ill
patient
icu
group
carvi
except
season
influenza
ab
higher
allcaus
mortal
rate
transplant
recipi
carvi
except
influenza
transplant
recipi
could
occur
late
posttranspl
period
sever
year
especi
adv
infect
promin
hsct
recipi
studi
suggest
import
suspicion
diagnosi
carvi
transplant
recipi
even
late
posttranspl
period
nontranspl
critic
ill
patient
icu
older
age
particularli
mv
none
none
author
declar
conflict
interest
associ
manuscript
